This page in Swedish

Anna Björkenheim

Title: Affiliated Researcher School/office: School of Medical Sciences

Email:

Phone: +46 19 303000

Room: -

Research subject

Publications

Articles in journals |  Conference papers |  Doctoral theses, comprehensive summaries | 

Articles in journals

Jackson, A. , Fröbert, O. , Boye Larsen, D. , Arendt-Nielsen, L. & Björkenheim, A. (2021). Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation. Open heart, 8 (1).
Björkenheim, A. , Szabó, B. & Sztaniszláv, Á. J. (2020). Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation. BMJ case reports, 13 (1).
Björkenheim, A. , Cha, S. & Dioubanova, I. (2019). Haemolytic anaemia after mitral valve repair due to recurrent mild to moderate mitral regurgitation. BMJ case reports, 12 (8).
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 7 (5).
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poçi, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. European Heart Journal, 39 (Suppl. 1), 1415-1415.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Assessment of Atrial Fibrillation–Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?. JACC: Clinical Electrophysiology, 3 (10), 1168-1176.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poçi, D. (2017). Does zero atrial fibrillation burden after atrial fibrillation ablation mean that patients are free of symptoms?. Europace, Supplements, 19 (Duppl. 3), iii264-iii264.
Björkenheim, A. , Brandes, A. , Chemnitz, A. , Magnuson, A. , Edvardsson, N. & Poçi, D. (2016). Rhythm Control and its Relation to Symptoms During the First Two Years After Radiofrequency Ablation for Atrial Fibrillation. Pacing and Clinical Electrophysiology, 39 (9), 914-925.
Björkenheim, A. , Brandes, A. , Andersson, T. , Magnuson, A. , Edvardsson, N. , Wandt, B. , Pedersen, H. S. & Poci, D. (2014). Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillation. Europace, 16 (12), 1772-1778.

Conference papers

Björkenheim, A. (2019). Hemolytic anemia and renal failure after mitral valve repair for mitral regurgitation. Paper presented at ESC Congress, 2019, Paris, France, 31 August-04 September, 2019.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. & Poci, D. (2018). Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument. Paper presented at European Society of Cardiology Congress 2018, Munich, Germany, August 25-29, 2018.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Edvardsson, N. G. & Poci, D. (2018). Patient-reported Outcomes In Relation To Continuously Monitored Rhythm Before And During Two Years After Atrial Fibrillation Ablation Using A Disease-specific And A Generic Instrument. Paper presented at HRS 39th Annual Scientific Sessions, Boston, USA, May 9-12, 2018.
Björkenheim, A. , Brandes, A. , Magnuson, A. , Chemnitz, A. , Svedberg, L. , Edvardsson, N. & Poci, D. (2017). Is AF burden <0.5% a clinically meaningful criterion of success after AF ablation?. Paper presented at 13th Annual Congress of ECAS 2017, Rome, April 2-4, 2017.

Doctoral theses, comprehensive summaries

Björkenheim, A. (2018). Catheter ablation for atrial fibrillation: effects on rhythm, symptoms and health-related quality of life. (Doctoral dissertation). (Comprehensive summary) Örebro: Örebro University.